Here, we first fused glioma-targeting motifs on the surface of HFn NPs through a genetic engineering method and constructed a STING agonist-loaded fusion protein NP platform capable of penetrating deep tumor tissues and targeting gliomas after traversing the BBB. Here, STING1 is linked to central nervous system cancer.